- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03057678
Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery (PPF)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mastoidectomy is a common otologic surgical procedure in which all or part of the mastoid portion of the temporal bone is removed with a surgical drill. The procedure is performed to treat diseases and infections such as mastoiditis and cholesteatoma, and is also performed as one step of other surgeries, such as the facial recess approach for cochlear implantation (CI) or the translabyrinthine approach for acoustic neuroma removal (TANR). The investigators are working on a new medical device to assist specifically with the TANR procedure. The focus of this study is one component of this device, the pre-positioning frame (PPF).
TANR surgery is performed to remove benign tumors on the auditory nerve which can cause severe hearing and balance problems if not removed. The current standard of care is a mastoidectomy, followed by a labyrinthectomy (excision of the labyrinth of the inner ear) to gain access to the skull base, specifically the internal auditory canal (IAC), where tumors are located.
Several critical anatomical structures are embedded in the mastoid bone, including the facial nerve, which controls motion of the face, large blood vessels such as the carotid artery and intracranial continuation of the jugular vein, and the tegmen, which is the boundary between the mastoid and the brain. Surgeons are specially trained to recognize and avoid these structures when drilling. Drilling for TANR surgery often takes several hours due to slow advancement of the drill through hard bone in the labyrinth region. After this drilling is when the most delicate and critical portion of the surgery begins i.e. removal of the acoustic neuroma. The investigators hypothesize that a robot, guided by pre-operative images, can perform the drilling for TANR surgery while preserving safe margins around the critical structures thus enabling surgeons to focus on the delicate, final stage of TANR surgery.
There are several robotic systems available for orthopedic drilling procedures such as joint arthroplasty and resurfacing. These systems include the RIO System (Stryker Mako, Ft. Lauderdale, FL, USA), the ROBODOC Surgical System (Think Surgical Corp., Fremont, CA, USA) and the CASPAR (URS Ortho GMBH & Co. KG, Rastatt, Germany). However, these systems have not been shown accurate enough to perform TANR surgery safely, and rely on expensive image guidance systems to continuously track the patient's position relative to the robot, in order to ensure that the robot-guided drill stays within safe margins.
The investigators previously designed a small light-weight robot that can be attached to the bone of a patient's head, and provide the required accuracy for TANR surgery without an expensive image guidance system.
To reach an entire mastoidectomy volume for TANR surgery, our robot must be correctly positioned relative to a patient's temporal bone anatomy. The investigators hypothesize that a rigid fixture, which the investigators call a pre-positioning frame (PPF), can correctly position our robot to complete drilling for TANR surgery on the patient population. The goal of this study is to investigate the first step in implementing this system by attaching a PPF to a patient who is undergoing a standard TANR surgery in order to better understand the time it takes to do this step and optimize the surgical workflow.
The PPF, attaches directly to the participants head behind the ear, using bone screws adapted from cranial reconstruction hardware. These bone screws are typically used in this area of the skull and placed at a similar penetration depth of 3.5 mm. The safety margin from tip of the screw to the inside skull surface will be 0.25mm In a future study, the robot would then attach to fiducial markers on the top surface of the PPF. Our current PPF design incorporates data from ten robotic drilling experiments. Six trials were performed on excised temporal bones, and four were performed on full cadaver heads. Using results from these experiments, the investigators improved the shape of the PPF to optimally reach the range of planned TANR mastoidectomy volumes, and also improved the legs of the PPF to facilitate rapid and secure implantation of bone screws.
The surgical workflow the investigators plan for a full robotic mastoidectomy will be described here for context, but to be clear, steps 7, 8, and 10 will not be performed in the proposed study.
- Prior to surgery, a surgeon manually segments a mastoidectomy volume in a preoperative CT image using investigational software created for this purpose.
- During surgery, the PPF is anchored to the temporal bone with self-drilling bone screws.
- An intraoperative CT scan is acquired of the participants's head with the PPF attached using a portable CT scanner.
- The intraoperative CT image is registered to the preoperative CT and the pre-operative segmentations are transformed to the intraoperative CT using the registration.
- Fiducial markers on the PPF are localized in the intraoperative CT image, allowing the pre-operative segmentation data to be transformed to the intraoperative CT image space.
- Robot motion is automatically planned using investigational mastoidectomy planning software.
- (The robot is fastened to the fiducial markers on the PPF, and is activated to execute the drill trajectory. The surgeon retains supervisory control over the robot and can stop or alter its speed if necessary).
- (The robot is removed from the PPF following completion of drilling).
- The PPF is removed from the participant by loosening the bone screws.
- (The surgeon completes the manual surgical actions that follow mastoidectomy drilling, such as removal of IAC tumors.) The investigators plan to clinically validate the improved PPF design by performing the steps above (excluding steps 7, 8, and 10) on ten participants. Note that the PPF will be removed directly after step 5 when the CT image has been registered. Using previously developed robotic mastoidectomy planning software (step 6), the investigators will calculate the percentage of each TANR mastoidectomy that is reachable for an attached PPF configuration. Step 6 will be done once the images have been collected and will not impact the clinical procedure.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients 21-80 years old undergoing TANR who consent to participation.
- Preop Head CT scan as part of routine care.
- Skull thickness a minimum of 3.75mm in planned attachment areas.
Exclusion Criteria:
- Pregnant women. As per standard of care in preparation for surgery, all females of childbearing age will undergo a pregnancy test during the medical evaluation for surgery.
- Patients with severe comorbidities, such as chronic otitis media, history of stroke, brain trauma, or hydrocephalus.
- Patients with a history of allergic reactions to lidocaine.
- Patients with severe anatomical abnormality of the temporal bone.
- Patients with history of allergic reaction to titanium, because the bone screws used in this study are made of a titanium alloy.
- Patients who are at unacceptable risk for general anesthesia.
- Patients who are at unacceptable risk for the intraoperative CT scan(s).
- Patients who are unable to give informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Testing of Pre-Positioning Frame
Placement of bone screws, CT scanning, Surgical planning, Robot motion planning
|
Placement of bone screws, CT scanning, Surgical planning, Robot motion planning
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time in minutes required to attach the PPF.
Time Frame: From PPF anchored to temporal bone until bone screws are loosened and PPF removed, estimated 15-30 minutes.
|
From PPF anchored to temporal bone until bone screws are loosened and PPF removed, estimated 15-30 minutes.
|
Percentage of planned mastoidectomy reachable by robot
Time Frame: During the use of the PPF, estimated 15-30 minutes.
|
During the use of the PPF, estimated 15-30 minutes.
|
Collaborators and Investigators
Investigators
- Study Director: Robert J. Webster, PhD, Vanderbilt University
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Otorhinolaryngologic Neoplasms
- Otorhinolaryngologic Diseases
- Neuroectodermal Tumors
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Nerve Tissue
- Ear Diseases
- Nervous System Neoplasms
- Cranial Nerve Diseases
- Neuroendocrine Tumors
- Nerve Sheath Neoplasms
- Peripheral Nervous System Neoplasms
- Cranial Nerve Neoplasms
- Neurilemmoma
- Vestibulocochlear Nerve Diseases
- Retrocochlear Diseases
- Neuroma
- Neuroma, Acoustic
Other Study ID Numbers
- 151347
- R01DC012593 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acoustic Neuroma
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Active, not recruitingSporadic Acoustic Neuromas | Useful HearingItaly
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingVestibular Schwannoma | Acoustic Neuroma | Neurinoma, Acoustic
-
University of North Carolina, Chapel HillMed-El CorporationCompletedMeniere's Disease | Unilateral Acoustic NeuromaUnited States
-
Stanford UniversityBaylor College of Medicine; University of Iowa; Weill Medical College of Cornell... and other collaboratorsCompletedNeuroma, AcousticUnited States
-
Taipei Medical University Shuang Ho HospitalUnknown
-
University Hospital, Strasbourg, FranceUnknownNeuroma, AcousticFrance
-
Rigshospitalet, DenmarkUnknown
-
Massachusetts General HospitalNational Cancer Institute (NCI)Active, not recruitingVestibular Schwannoma | Acoustic NeuromaUnited States
-
University Hospital, BordeauxUnknown
-
Oticon MedicalCompletedHearing Loss, Cochlear | Neurinoma of the Acoustic NerveFrance
Clinical Trials on Testing of Pre-Positioning Frame
-
Robert Jones and Agnes Hunt Orthopaedic and District...University of ExeterNot yet recruitingTibialis Posterior Dysfunction | Emg
-
Istituto Clinico HumanitasCompletedAneuploidy | Genetic Disease
-
Haukeland University HospitalUniversity of BergenRecruitingSuicide, Attempted | Borderline Personality Disorder | Self Harm | Emotional InstabilityNorway
-
Inesa AstramskaitėCompleted
-
Wills EyeCompletedCataractUnited States
-
University of Maryland, BaltimoreRecruiting
-
Tanta UniversityCompletedRadiotherapy Side EffectEgypt
-
St. Jude Children's Research HospitalCompletedSickle Cell DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingFollicular LymphomaUnited States
-
University of Split, School of MedicineCompleted